SWAV vs. INSP, CMD, NARI, RMD, WST, BAX, PODD, SOLV, TFX, and GMED
Should you be buying Shockwave Medical stock or one of its competitors? The main competitors of Shockwave Medical include Inspire Medical Systems (INSP), Cantel Medical (CMD), Inari Medical (NARI), ResMed (RMD), West Pharmaceutical Services (WST), Baxter International (BAX), Insulet (PODD), Solventum (SOLV), Teleflex (TFX), and Globus Medical (GMED). These companies are all part of the "medical" sector.
Inspire Medical Systems (NYSE:INSP) and Shockwave Medical (NASDAQ:SWAV) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings, risk and community ranking.
In the previous week, Inspire Medical Systems and Inspire Medical Systems both had 8 articles in the media. Shockwave Medical's average media sentiment score of 1.23 beat Inspire Medical Systems' score of 0.58 indicating that Inspire Medical Systems is being referred to more favorably in the media.
94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 95.4% of Shockwave Medical shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by company insiders. Comparatively, 3.4% of Shockwave Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Shockwave Medical has a net margin of 20.75% compared to Shockwave Medical's net margin of -2.38%. Inspire Medical Systems' return on equity of 24.79% beat Shockwave Medical's return on equity.
Inspire Medical Systems received 43 more outperform votes than Shockwave Medical when rated by MarketBeat users. Likewise, 61.03% of users gave Inspire Medical Systems an outperform vote while only 55.83% of users gave Shockwave Medical an outperform vote.
Shockwave Medical has higher revenue and earnings than Inspire Medical Systems. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Shockwave Medical, indicating that it is currently the more affordable of the two stocks.
Inspire Medical Systems presently has a consensus target price of $256.53, suggesting a potential upside of 59.93%. Shockwave Medical has a consensus target price of $309.11, suggesting a potential downside of 7.68%. Given Shockwave Medical's stronger consensus rating and higher probable upside, analysts clearly believe Inspire Medical Systems is more favorable than Shockwave Medical.
Inspire Medical Systems has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500. Comparatively, Shockwave Medical has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500.
Summary
Shockwave Medical beats Inspire Medical Systems on 9 of the 17 factors compared between the two stocks.
Get Shockwave Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SWAV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Shockwave Medical Competitors List
Related Companies and Tools